Molteni Therapeutics products are made to sustain and improve the patient’s quality of life, to help physicians in the clinical practices, to meet the unmet medical needs
Molteni Therapeutics Receives CE Mark for Its New light source VULNOLIGHT®
Florence, February 2014
Florence (Italy) – Molteni Therapeutics Srl announced that it received CE Mark* approval for its new light source VULNOLIGHT®. With VULNOLIGHT® the company will start the out-licensing activity of the new, proprietary bi-modal (Light + Photosensitizer) approach of PDT in the field of wound care.VULNOLIGHT® is a LED based light source emitting at 630 nm designed to activating VULNOFAST® plus and enable the physicians with another tools to fight chronic wounds.
* The CE Mark indicates that the product satisfies requirements of EU Directives (EU:The European Union) and all products need to be CE certified to be sold in Europe.